Data di Pubblicazione:
2023
Citazione:
Are Phe-Free Protein Substitutes Available in Italy for Infants with PKU All the Same? / E. Verduci, M. Tosi, C. Montanari, M. Gambino, F. Eletti, A. Bosetti, M. Di Costanzo, M.T. Carbone, G. Biasucci, L. Fiori, G. Zuccotti. - In: NUTRIENTS. - ISSN 2072-6643. - 16:1(2023 Dec), pp. 30.1-30.21. [10.3390/nu16010030]
Abstract:
Breastfeeding or standard infant formulas, alongside phenylalanine (Phe)-free protein substitutes, constitute the dietary management for infants with PKU to guarantee protein requirements are met in compliance with metabolic tolerance. This work aims to analyse the nutritional composition of Phe-free infant protein substitutes, in terms of macronutrients, micronutrients and functional components, available for PKU dietary management in Italy. A total of seven infant Phe-free protein substitutes were included in this review, six powder and one liquid. A second analysis was conducted to compare them to the composition of formulas intended for healthy infants, taking into consideration the Commission Delegated Regulation (EU) 2016/127 and Commission Delegated Regulation (EU) 2016/128 for micronutrients. The analysis revealed heterogeneity among protein substitutes suitable for infants with PKU. The energy and protein equivalents (P.Eq.) content are different; all of the substitutes contain docosahexaenoic acid (DHA) and arachidonic acid (ARA), while eicosapentaenoic acid (EPA), fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), human milk oligosaccharides (HMOs) and nucleotides are not present in all the substitutes. More attention should be paid to these infant products to ensure metabolic control of PKU, and also promote proper growth, cognitive neurodevelopment, favourable gut microbiota composition, and immune system health, while reducing the risk for non-communicable diseases (NCDs).
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
phenylketonuria; infant nutrition; Phe-free protein substitutes; docosahexaenoic acid; arachidonic acid; biotics; non-communicable diseases prevention;
Elenco autori:
E. Verduci, M. Tosi, C. Montanari, M. Gambino, F. Eletti, A. Bosetti, M. Di Costanzo, M.T. Carbone, G. Biasucci, L. Fiori, G. Zuccotti
Link alla scheda completa: